BRUKER CORPORATION Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax of $26.10 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax · last filed 2024-11-07
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for the quarter ending 2024-09-30 was $26.10M.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for the quarter ending 2024-06-30 was $2.30M, a 54.00% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for the quarter ending 2024-03-31 was -$19.10M, a 661.76% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for the quarter ending 2023-12-31 was $22.20M.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for fiscal 2023 was $23.80M.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for fiscal 2022 was -$13.80M, a 210.40% decline from fiscal 2021.
- BRUKER CORPORATION other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax for fiscal 2021 was $12.50M.
| Period end | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax 3 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax 6 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax 9 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax 12 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $26.10M 10-Q · filed 2024-11-07 | $28.40M derived: sum of 2 quarters · filed 2024-11-07 | $9.30M 10-Q · filed 2024-11-07 | $31.50M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-09 | -$16.80M 10-Q · filed 2024-08-09 | $5.40M derived: sum of 3 quarters · filed 2024-08-09 | -$1.30M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-03-31 | -$19.10M 10-Q · filed 2024-05-10 | $3.10M derived: sum of 2 quarters · filed 2024-05-10 | -$3.60M derived: sum of 3 quarters · filed 2024-11-07 | $1.40M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-12-31 | $22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $15.50M derived: sum of 2 quarters · filed 2024-11-07 | $20.50M derived: sum of 3 quarters · filed 2024-11-07 | $23.80M 10-K · filed 2024-02-29 | |
| 2023-09-30 | -$6.70M 10-Q · filed 2024-11-07 | -$1.70M derived: sum of 2 quarters · filed 2024-11-07 | $1.60M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $5.00M 10-Q · filed 2024-08-09 | $8.30M 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | $3.40M 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | -$13.80M 10-K · filed 2024-02-29 | $13.80M 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $12.50M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |